“…Although there are multiple acceptable modalities for colorectal cancer (CRC) screening in the United States such as fecal occult blood test (FOBT) and fecal DNA testing, double contrast barium enema, CT colonography, flexible sigmoidoscopy, and colonoscopy (Levin et al, 2008), the uptake of CRC screening is suboptimal in the general population (Carcaise-Edinboro and Bradley, 2008; Palmer et al, 2011; Seeff et al, 2004; Shapiro et al, 2001; Shapiro et al, 2008). Previous studies have shown that a lack of patient awareness is a commonly reported barrier to undergoing screening, while having seen a physician within the past year, spending adequate time discussing screening, and lower perceived barriers to CRC testing are strongly associated with increased uptake of CRC screening (Bazargan et al, 2009; Carcaise-Edinboro and Bradley, 2008; Seeff et al, 2004).…”